Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Blow my brains out on June 3rd PR strategy

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson May 26, 2023 12:09pm

179 Views

Post# 35465899

Blow my brains out on June 3rd PR strategy

I am not happy with not having what I wanted yesterday.

That being said, managmenet is rolling out their PR strategy.
No good reason to sell imo as there appears to be lots more to come.

The additional data set at May 2023 must be very nice for them to do this and retain.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Sept. 27, 2024)